- CA$1.75bn
- CA$1.51bn
- CA$454.02m
- 97
- 46
- 54
- 72
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 386 | 504 | 467 | 428 | 454 |
Cost of Revenue | |||||
Gross Profit | 267 | 359 | 338 | 297 | 304 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 306 | 386 | 354 | 334 | 372 |
Operating Profit | 80.3 | 118 | 113 | 93.5 | 82.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 84.2 | 122 | 107 | 96.2 | 87.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 70.8 | 98.6 | 92.8 | 94.5 | 72.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 70.8 | 98.6 | 92.8 | 94.5 | 72.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 70.8 | 98.6 | 92.8 | 94.5 | 72.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.31 | 1.79 | 1.67 | 1.71 | 1.34 |
Dividends per Share | |||||
Special Dividends per Share |